Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P20366 (
substance P
)
21,176
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The loss of collagen organization is considered a hallmark histopathologic feature of tendinosis. At the cellular level, tenocytes have been shown to produce signal substances that were once thought to be restricted to neurons. One of the main neuropeptides implicated in tendinosis,
substance P
(SP), is known to influence collagen organization, particularly after injury. The aim of this study was to examine the influence of SP on collagen remodeling by primary human tendon cells cultured in vitro in three-dimensional collagen lattices. We found that SP stimulation led to an increased rate of collagen remodeling mediated via the neurokinin-1 receptor (NK-1 R), the preferred cell receptor for SP. Gene expression analysis showed that SP stimulation resulted in significant increases in MMP3, COL3A1 and
ACTA2
mRNA levels in the collagen lattices. Furthermore, cyclic tensile loading of tendon cell cultures along with the administration of exogenous SP had an additive effect on MMP3 expression. Immunoblotting confirmed that SP increased MMP3 protein levels via the NK-1 R. This study indicates that SP, mediated via NK-1 R, increases collagen remodeling and leads to increased MMP3 mRNA and protein expression that is further enhanced by cyclic mechanical loading.
...
PMID:Substance P enhances collagen remodeling and MMP-3 expression by human tenocytes. 2283 29
It was reported that
substance P
had beneficial effects in the healing of acute tendon injury. However, the relationship between
substance P
and degenerative tendinopathy development remains unclear. The purpose of this study was to determine the role of
substance P
in the pathogenesis of tendinopathy. Healthy and tendinopathy tendon were harvested from human and tenocytes were cultured individually. The expression levels of genes associated with tendinopathy were compared. Next,
substance P
was exogenously administered to the healthy tenocyte and the effect was evaluated. The results showed that tendinopathy tenocytes had higher levels of
COL3A1
,
MMP1
,
COX2
,
SCX
,
ACTA2
, and
substance P
gene expression compared to healthy tenocytes. Next,
substance P
treatment on the healthy tenocyte displayed similar changes to that of the tendinopathy tenocytes. These differences between the two groups were also determined by Western blot. Additionally, cells with
substance P
had the tendinopathy change morphologically although cellular proliferation was significantly higher compared to that of the control group. In conclusion,
substance P
enhanced cellular proliferation, but concomitantly increased immature collagen (type 3 collagen).
Substance P
plays a crucial role in tendinopathy development and could be a future therapeutic target for treatment.
...
PMID:The Implication of Substance P in the Development of Tendinopathy: A Case Control Study. 2859 90